Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival

BioMed Research International
Jee-Eun KimJung-Joon Sung

Abstract

Glycogen synthase kinase-3β (GSK-3β) inhibitors have been suggested as a core regulator of apoptosis and have been investigated as therapeutic agents for neurodegenerative diseases, including amyotrophic lateral sclerosis. However, GSK-3β has an interesting paradoxical effect of being proapoptotic during mitochondrial-mediated intrinsic apoptosis but antiapoptotic during death receptor-mediated extrinsic apoptosis. We assessed the effect of low to high doses of a GSK-3β inhibitor on survival and apoptosis of the NSC-34 motor neuron-like cell line after serum withdrawal. Then, we identified changes in extrinsic apoptosis markers, including Fas, Fas ligand, cleaved caspase-8, p38α, and the Fas-Daxx interaction. The GSK-3β inhibitor had an antiapoptotic effect at the low dose but was proapoptotic at the high dose. Proapoptotic effect at the high dose can be explained by increased signals in cleaved caspase-8 and the motor neuron-specific p38α and Fas-Daxx interaction. Our results suggest that GSK-3β inhibitor dose may determine the summation effect of the intrinsic and extrinsic apoptosis pathways. The extrinsic apoptosis pathway might be another therapeutic target for developing a potential GSK-3β inhibitor.

References

Oct 6, 1997·The Journal of Biological Chemistry·M HongV M Lee
Aug 1, 1998·The Journal of Biological Chemistry·M Pap, G M Cooper
Sep 2, 2000·Current Opinion in Neurology·A Al-Chalabi, P N Leigh
Aug 31, 2001·Progress in Neurobiology·C A Grimes, R S Jope
Mar 7, 2002·Trends in Molecular Medicine·Hagit Eldar-Finkelman
Jun 6, 2002·Journal of Chemical Neuroanatomy·Hong-Bing YaoDavid Chi-Cheong Wan
Dec 8, 2004·The European Journal of Neuroscience·Fuminobu SugaiSaburo Sakoda
Jul 28, 2005·The European Journal of Neuroscience·Seong-Ho KohSeung Hyun Kim
Apr 4, 2006·Proceedings of the National Academy of Sciences of the United States of America·C RaoulG Haase
May 9, 2006·European Journal of Pharmacology·Justin S LaiPeter P Li
May 16, 2007·Annals of Neurology·Federica LocatelliGiacomo Pietro Comi
Mar 28, 2009·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Tameko KihiraRalph M Garruto
Sep 14, 2010·Journal of Neurochemistry·Marc P M SoutarCalum Sutherland
Feb 8, 2011·Biochimica Et Biophysica Acta·Chahrazade Kantari, Henning Walczak
Jun 2, 2011·International Journal of Alzheimer's Disease·Peng LeiPaul A Adlard
Apr 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nathalie Bernard-MarissalBrigitte Pettmann

❮ Previous
Next ❯

Citations

Aug 13, 2020·Cellular & Molecular Biology Letters·Shuangyang TangYimou Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
immunoprecipitation assay
protein assay
immunoprecipitation

Software Mentioned

CellQuest
GraphPad Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.